Vergis, J. and McCullumsmith, R.E. (2025) “Pathway enrichment and FDA-approved drug repurposing analysis for the treatment of CTNNB1 Syndrome modeled in an SH-SY5Y cell line”, Translation: The University of Toledo Journal of Medical Sciences, 14(S1). doi:10.46570/utjms-2025-1507.